Single User License
INR 136360
Site License
INR 272720
Corporate User License
INR 409080

Service Tax Additional

select a format
Price

Single User License
USD 2000
Site License
USD 4000
Corporate User License
USD 6000

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Hand, Foot And Mouth Disease-Pipeline Review, H2 2015

Hand, Foot And Mouth Disease-Pipeline Review, H2 2015


  Request for Sample Report

Executive Summary

Hand, Foot And Mouth Disease-Pipeline Review, H2 2015

Summary

Global Markets Direct's, 'Hand, Foot And Mouth Disease-Pipeline Review, H2 2015', provides an overview of the Hand, Foot And Mouth Disease's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Hand, Foot And Mouth Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hand, Foot And Mouth Disease and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Hand, Foot And Mouth Disease

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Hand, Foot And Mouth Disease and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Hand, Foot And Mouth Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Hand, Foot And Mouth Disease pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Hand, Foot And Mouth Disease

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Hand, Foot And Mouth Disease pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Hand, Foot And Mouth Disease Overview 6

Therapeutics Development 7

Pipeline Products for Hand, Foot And Mouth Disease-Overview 7

Pipeline Products for Hand, Foot And Mouth Disease-Comparative Analysis 8

Hand, Foot And Mouth Disease-Therapeutics under Development by Companies 9

Hand, Foot And Mouth Disease-Therapeutics under Investigation by Universities/Institutes 10

Hand, Foot And Mouth Disease-Pipeline Products Glance 11

Late Stage Products 11

Clinical Stage Products 12

Early Stage Products 13

Hand, Foot And Mouth Disease-Products under Development by Companies 14

Hand, Foot And Mouth Disease-Products under Investigation by Universities/Institutes 15

Hand, Foot And Mouth Disease-Companies Involved in Therapeutics Development 16

Chongqing Zhifei Biological Products Co., Ltd. 16

CJ CheilJedang Corp. 17

iQur Limited 18

Sentinext Therapeutics Sdn Bhd 19

Sinovac Biotech Ltd. 20

Takeda Pharmaceutical Company Limited 21

Hand, Foot And Mouth Disease-Therapeutics Assessment 22

Assessment by Monotherapy Products 22

Assessment by Combination Products 23

Assessment by Route of Administration 24

Assessment by Molecule Type 25

Drug Profiles 27

CJ-40010-Drug Profile 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

coxsackievirus [serotype A16] + enterovirus [serotype 71] vaccine-Drug Profile 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

D-5-Drug Profile 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

enterovirus [serotype 71] vaccine-Drug Profile 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

foot and mouth disease virus like particle vaccine-Drug Profile 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

hand foot and mouth disease vaccine-Drug Profile 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

hand, foot and mouth (bivalent) viral like particle vaccine-Drug Profile 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

TAK-021-Drug Profile 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Hand, Foot And Mouth Disease-Recent Pipeline Updates 36

Hand, Foot And Mouth Disease-Product Development Milestones 40

Featured News & Press Releases 40

May 14, 2015: Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities 40

Apr 24, 2014: Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project 40

Feb 26, 2014: Sinovac's EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine 41

May 30, 2013: Sinovac Files New Drug Application For EV71 Vaccine And Receives Filing Acceptance From Beijing Drug Administration 42

Apr 18, 2013: Sinovac Announces Presentation Of EV71 Vaccine Phase III Top-Line Results At 13th Annual World Vaccine Congress & Expo 42

Mar 14, 2013: Sinovac Reports Positive Preliminary Top-Line Results From Phase III Clinical Trial For EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease 43

Jun 25, 2012: Sinovac Reports Progress In EV71 Vaccine Phase III Clinical Trial And Commercialization Preparation Status 44

Jun 11, 2012: Sinovac Reports Progress In EV71 Vaccine Phase III Clinical Trial 44

Mar 29, 2012: Sinovac Announces Publication Of Phase I Clinical Data Of EV71 Vaccine For Prevention Of Hand, Foot And Mouth Disease In Journal Vaccine 45

Mar 11, 2012: Inviragen Reports Top-Line Results From Phase I Trial Of INV21 Vaccine For Treatment Of Hand, Foot And Mouth Disease 46

Appendix 47

Methodology 47

Coverage 47

Secondary Research 47

Primary Research 47

Expert Panel Validation 47

Contact Us 47

Disclaimer 48

List of Tables

Number of Products under Development for Hand, Foot And Mouth Disease, H2 2015 7

Number of Products under Development for Hand, Foot And Mouth Disease-Comparative Analysis, H2 2015 8

Number of Products under Development by Companies, H2 2015 9

Number of Products under Investigation by Universities/Institutes, H2 2015 10

Comparative Analysis by Late Stage Development, H2 2015 11

Comparative Analysis by Clinical Stage Development, H2 2015 12

Comparative Analysis by Early Stage Development, H2 2015 13

Products under Development by Companies, H2 2015 14

Products under Investigation by Universities/Institutes, H2 2015 15

Hand, Foot And Mouth Disease-Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H2 2015 16

Hand, Foot And Mouth Disease-Pipeline by CJ CheilJedang Corp., H2 2015 17

Hand, Foot And Mouth Disease-Pipeline by iQur Limited, H2 2015 18

Hand, Foot And Mouth Disease-Pipeline by Sentinext Therapeutics Sdn Bhd, H2 2015 19

Hand, Foot And Mouth Disease-Pipeline by Sinovac Biotech Ltd., H2 2015 20

Hand, Foot And Mouth Disease-Pipeline by Takeda Pharmaceutical Company Limited, H2 2015 21

Assessment by Monotherapy Products, H2 2015 22

Assessment by Combination Products, H2 2015 23

Number of Products by Stage and Route of Administration, H2 2015 24

Number of Products by Stage and Molecule Type, H2 2015 26

Hand, Foot And Mouth Disease Therapeutics-Recent Pipeline Updates, H2 2015 36

List of Figures

Number of Products under Development for Hand, Foot And Mouth Disease, H2 2015 7

Number of Products under Development for Hand, Foot And Mouth Disease-Comparative Analysis, H2 2015 8

Number of Products under Development by Companies, H2 2015 9

Comparative Analysis by Early Stage Products, H2 2015 13

Assessment by Monotherapy Products, H2 2015 22

Number of Products by Stage and Top 10 Routes of Administration, H2 2015 24

Number of Products by Top 10 Molecule Types, H2 2015 25

Number of Products by Stage and Top 10 Molecule Types, H2 2015 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Chongqing Zhifei Biological Products Co., Ltd.

CJ CheilJedang Corp.

iQur Limited

Sentinext Therapeutics Sdn Bhd

Sinovac Biotech Ltd.

Takeda Pharmaceutical Company Limited

Hand, Foot And Mouth Disease Therapeutic Products under Development, Key Players in Hand, Foot And Mouth Disease Therapeutics, Hand, Foot And Mouth Disease Pipeline Overview, Hand, Foot And Mouth Disease Pipeline, Hand, Foot And Mouth Disease Pipeline Assessment


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com